Follow
Sherry Mortach
Sherry Mortach
Unknown affiliation
Verified email at case.edu
Title
Cited by
Cited by
Year
The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastoma
MM Tallman, AA Zalenski, AM Deighen, MS Schrock, S Mortach, ...
Cancer Letters 499, 232-242, 2021
162021
SMALL MOLECULE DRUG CBL0137 INHIBITS THE FACT COMPLEX AND SENSITIZES GLIOBLASTOMA CANCER STEM CELLS TO RADIOTHERAPY
M Tallman, A Zalenski, A Deighen, M Schrock, S Mortach, T Grubb, ...
NEURO-ONCOLOGY 22, 202-202, 2020
2020
STEM-26. SMALL MOLECULE DRUG CBL0137 INHIBITS THE FACT COMPLEX AND SENSITIZES GLIOBLASTOMA CANCER STEM CELLS TO RADIOTHERAPY
M Tallman, A Zalenski, A Deighen, M Schrock, S Mortach, T Grubb, ...
Neuro-Oncology 22 (Suppl 2), ii201, 2020
2020
STEM-20. RADIO-SENSITIZING GLIOBLASTOMA CANCER STEM CELLS BY INHIBITION OF FACT
M Montgomery, A Zalenski, A Deighen, S Mortach, T Grubb, M Venere
Neuro-Oncology 21 (Suppl 6), vi237, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–4